Analysis of the BCR-ABL protein in Philadelphia chromosome positive adult acute lymphocytic leukemia (ALL) by enhanced chemiluminiscence western blotting (Eq-WB).

被引：0
|
作者：
Bseiso, AW
Kantarjian, HM
Guo, JQ
Talpaz, M
OBrien, S
Koller, C
Albitar, M
Keating, M
Arlinghaus, R
机构：
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT HEMATOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT MOL PATHOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT BIOIMMUNOTHERAPY,HOUSTON,TX 77030
[4] UNIV TEXAS,MD ANDERSON CANCER CTR,LAB MED,HOUSTON,TX 77030
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3335 / 3335
页数：1
相关论文
共 50 条
  • [41] Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia
    Boulos, Nidal
    Mulder, Heather L.
    Calabrese, Christopher R.
    Morrison, Jeffrey B.
    Rehg, Jerold E.
    Relling, Mary V.
    Sherr, Charles J.
    Williams, Richard T.
    BLOOD, 2011, 117 (13) : 3585 - 3595
  • [42] Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Abdelrasoul, Hend
    Vadakumchery, Anila
    Werner, Markus
    Lenk, Lennart
    Khadour, Ahmad
    Young, Marc
    El Ayoubi, Omar
    Vogiatzi, Fotini
    Kraemer, Markus
    Schmid, Vera
    Chen, Zhengshan
    Yousafzai, Yasar
    Cario, Gunnar
    Schrappe, Martin
    Mueschen, Markus
    Halsey, Christina
    Mulaw, Medhanie A.
    Schewe, Denis M.
    Hobeika, Elias
    Alsadeq, Ameera
    Jumaa, Hassan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] Ribozyme-mediated inhibition of a Philadelphia-chromosome positive acute lymphoblastic leukemia cell line expressing the P190 bcr-abl oncogene.
    Snyder, DS
    Wu, Y
    McMahon, R
    Yu, L
    Forman, SJ
    BLOOD, 1996, 88 (10) : 821 - 821
  • [44] Phase II study of combination of the HyperCVAD regimen with dasatinib in patients with Philadelphia chromosome (Ph) or BCR-ABL positive acute lymphoblastic leukemia (ALL) and lymphoid blast phase chronic myeloid leukemia (CML-LB)
    Ravandi, Farhad
    Thomas, Deborah
    Kantarjian, Hagop
    Faderl, Stefan
    Koller, Charles
    Brown, Devri
    Garris, Rebecca
    Borthakur, Gautam
    Burger, Jan
    Kebriaei, Partow
    Jorgensen, Jeffrey
    Jones, Dan
    Cortes, Jorge
    O'Brien, Susan
    BLOOD, 2007, 110 (11) : 828A - 828A
  • [45] Overriding drug resistance in Philadelphia chromosome-positive acute B lymphoblastic leukemia by targeting both BCR-ABL and MAP4K signaling pathways
    Ren, Ruibao
    Xiao, Xinhua
    Zhang, Jianming
    Jiao, Bo
    CANCER RESEARCH, 2019, 79 (13)
  • [46] SERIAL MONITORING OF BCR-ABL BY REAL-TIME POLYMERASE CHAIN REACTION IN NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH IMATINIB
    Lim, S.
    Joo, Y. D.
    Sohn, B. S.
    HAEMATOLOGICA, 2016, 101 : 350 - 350
  • [47] Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Hend Abdelrasoul
    Anila Vadakumchery
    Markus Werner
    Lennart Lenk
    Ahmad Khadour
    Marc Young
    Omar El Ayoubi
    Fotini Vogiatzi
    Markus Krämer
    Vera Schmid
    Zhengshan Chen
    Yasar Yousafzai
    Gunnar Cario
    Martin Schrappe
    Markus Müschen
    Christina Halsey
    Medhanie A. Mulaw
    Denis M. Schewe
    Elias Hobeika
    Ameera Alsadeq
    Hassan Jumaa
    Nature Communications, 11
  • [48] Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome positive acute lymphoblastic leukemia.
    Abdelrasoul, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 78 - 78
  • [49] Optimal Interval for Detection of Molecular Relapse after Stop of Tyrosine Kinase Inhibitor (TKI) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL) Caliculated By Kinetics of BCR-ABL Transcripts
    Miyamura, Koichi
    Osaki, Masahide
    Goto, Tatsunori
    Morishita, Takanobu
    Ozawa, Yukiyasu
    BLOOD, 2020, 136
  • [50] Pattern and evolution of BCR-ABL kinase domain mutations in patients with Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) developing resistance to imatinib.
    Pfeifer, H
    Wassmann, B
    Pavlova, A
    Mueller, M
    Wunderle, L
    Brueck, P
    Oldenburg, J
    Hochhaus, A
    Gschaidmeier, H
    Hoelzer, D
    Ottmann, OG
    BLOOD, 2005, 106 (11) : 46A - 47A
12345